कृपया अन्य खोज का प्रयास करें
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company’s lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Thomas Kuhn | - | 2009 | Co-Founder, CEO & Director |
Harold E. Lebovitz | - | - | Member of Scientific Advisory Board |
Mohammed Khoso Baluch | - | 2012 | Independent Chairman of the Board |
Kohjiro Ueki | - | - | Member of Scientific Advisory Board |
Pascale Boissel | 57 | 2015 | Independent Director |
Masato Kasuga | - | 2019 | Member of Scientific Advisory Board |
Richard N. Kender | 67 | 2015 | Independent Director |
Kenneth Cusi | - | 2019 | Member of Scientific Advisory Board |
Marc Engelen | - | 2021 | Member of Scientific Advisory Board |
Stephan Kemp | - | 2021 | Member of Scientific Advisory Board |
Keith van Haren | - | 2021 | Member of Scientific Advisory Board |
Ralph A. Defronzo | - | 2019 | Member of Scientific Advisory Board |
Edouard Guillet | - | 2022 | Observer to the Board of Directors |
Philip Newsome | - | 2021 | Member of the Scientific Advisory Board |
Hirotaka Watada | - | - | Member of Scientific Advisory Board |
Vlad Raziu | - | 2020 | Member of the Scientific Advisory Board |
S. Ali Fatemi | - | 2021 | Member of Scientific Advisory Board ? |
Stephen A. Harrison | - | 2019 | Member of Scientific Advisory Board |
Quentin Anstee | - | 2020 | Member of the Scientific Advisory Board |
Arun J. Sanyal | - | 2020 | Member of the Scientific Advisory Board |
John F. Amatruda | - | - | Member of Scientific Advisory Board |
Wataru Ogawa | - | - | Member of Scientific Advisory Board |
Fanny Mochel | - | 2021 | Member of Scientific Advisory Board |
Jaspreet Singh | - | 2021 | Member of Scientific Advisory Board |
Kohei Kaku | - | 2019 | Member of Scientific Advisory Board |
Gregory Steinberg | - | 2020 | Member of Scientific Advisory Board |
Florian Eichler | - | 2021 | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है